In scenarios where you may involve entry to a medically-important drug for a significant or everyday living-threatening condition the place there is absolutely no marketplace authorized drug offered in copyright and for which choice typical therapies have unsuccessful or are unsuitable, Overall health copyright's Specific Accessibility Programme (S